Skip to main content
. 2021 Jan 23;34:137–147. doi: 10.1016/j.jare.2021.01.009

Fig. 6.

Fig. 6

The schematic diagram of therapeutic mechanism of Nar against Hcy induced endothelial dysfunction. Obviously, Nar can elevate AMPKα/Sirt1 signaling pathway consequently rescue the Ca2+ disrupted mitochondrial function and reduce the ROS production. Furthermore, activated AMPKα/Sirt1 signaling pathway will upregulate the activity of downstream protein of eNOS subsequently increase the production of NO, ultimately ameliorate the ED.